Home/Filings/4/0001214659-18-005006
4//SEC Filing

Snider Lindy 4

Accession 0001214659-18-005006

CIK 0001625288other

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 1:41 PM ET

Size

6.1 KB

Accession

0001214659-18-005006

Insider Transaction Report

Form 4
Period: 2018-07-25
Snider Lindy
Director
Transactions
  • Award

    Stock option - right to buy

    2018-07-25+100,000100,000 total
    Exercise: $0.54From: 2018-07-25Exp: 2025-07-25Common Stock (100,000 underlying)
Holdings
  • Common Stock

    480,000
Footnotes (2)
  • [F1]25,000 options vested immediately, with the remainder vesting quarterly over the next 6 quarters beginning with the quarter ending September 30, 2018.
  • [F2]Granted under the Company's 2018 Equity Incentive Plan.

Issuer

Intiva BioPharma Inc.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001733367

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 1:41 PM ET
Size
6.1 KB